(Q41379869)

30 September 2017

Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency (English)

1 reference

30 September 2017

G M Mancini

1

1 reference

30 September 2017

A T Hoogeveen

2

1 reference

30 September 2017

H Galjaard

3

1 reference

30 September 2017

J E Mansson

4

1 reference

30 September 2017

L Svennerholm

5

1 reference

30 September 2017

language of work or name

1 reference

1 May 1986

1 reference

30 September 2017

1 reference

30 September 2017

73

1 reference

30 September 2017

1

1 reference

30 September 2017

35-38

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00292661

30 September 2017

0 references

cites work

A simple and novel method for tritium labeling of gangliosides and other sphingolipids

1 reference

12 December 2020

Macular cherry-red spots and myoclonus with dementia: Coexistent neuraminidase and β-galactosidase deficiencies

1 reference

12 December 2020

Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein

1 reference

12 December 2020

GM1-gangliosidosis. Defective recognition site on beta-galactosidase precursor

1 reference

12 December 2020

Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.

1 reference

12 December 2020

Model for the interaction of membrane-bound substrates and enzymes. Hydrolysis of ganglioside GD1a by sialidase of neuronal membranes isolated from calf brain.

1 reference

12 December 2020

Partial enzyme deficiencies: residual activities and the development of neurological disorders

1 reference

12 December 2020

Interactions of pig brain cytosolic sialidase with gangliosides. Formation of catalytically inactive enzyme-ganglioside complexes.

1 reference

12 December 2020

The relation between human lysosomal beta-galactosidase and its protective protein

1 reference

12 December 2020

Morquio disease, type B: activation of GM1-beta-galactosidase by GM1-activator protein

1 reference

12 December 2020

Generalized gangliosidosis: beta-galactosidase deficiency.

1 reference

12 December 2020

Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid beta-galactosidase deficiency

1 reference

12 December 2020

Morquio B syndrome: a primary defect in beta-galactosidase

1 reference

12 December 2020

Morquio-B disease, spondyloepiphyseal dysplasia associated with acid beta-galactosidase deficiency. Report of three cases in one family

1 reference

12 December 2020

Correction of combined beta-galactosidase/neuraminidase deficiency in human fibroblasts

1 reference

12 December 2020

The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates

1 reference

12 December 2020

Genetic heterogeneity in human neuraminidase deficiency.

1 reference

12 December 2020

Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency

1 reference

12 December 2020

Oligosaccharide and Ganglioside Neuraminidase Activities of Mucolipidosis I (Sialidosis) and Mucolipidosis II (I-Cell Disease) Fibroblasts

1 reference

12 December 2020

Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.

1 reference

12 December 2020

Sialidase deficiency in adult-type neuronal storage disease

1 reference

12 December 2020

Purification of acid beta-galactosidase and acid neuraminidase from bovine testis: evidence for an enzyme complex

1 reference

12 December 2020

Morquio syndrome (mucopolysaccharidosis IV B) associated with beta-galactosidase deficiency. Report of two cases.

1 reference

12 December 2020

CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00292661

1 reference

Dimensions Publication ID

30 September 2017

0 references

1 reference